Tigecycline resistance among Klebsiella pneumoniae isolated from febrile neutropenic patients

Journal of Medical Microbiology

Volumn 67, Issue 7, 2018, Pages 972-975

  Elgendy, Sherein G ^a   Abdel Hameed, Muhammad R ^b   El Mokhtar, Mohamed A ^a  

^a Assiut University Faculty of Medicine   (Egypt)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

Efflux pump genes; Febrile neutropenia; Klebsiella pneumoniae; Tigecycline resistance

Indexed keywords

AMIKACIN; CARBAPENEM DERIVATIVE; CEFOTAXIME; IMIPENEM; LEVOFLOXACIN; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; MINOCYCLINE;

ACRB GENE; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION ANALYSIS; EGYPT; FEBRILE NEUTROPENIA; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HIGH RISK PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; OQXB GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAMA GENE; RARA GENE; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECT; GENETICS; KLEBSIELLA INFECTION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NEUTROPENIA; PHYSIOLOGY; YOUNG ADULT;

ADULT; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; EGYPT; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINOCYCLINE; NEUTROPENIA; YOUNG ADULT;

EID: 85049400708     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000770     Document Type: Article

References (26)

1. Lakshmaiah KC, Malabagi AS, Govindbabu, Shetty R, Sinha M et al. Febrile neutropenia in hematological malignancies: clinical and microbiological profile and outcome in high risk patients. J Lab Physicians 2015;7:116–120.
2. Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 2005;40:S240–S245.
3. Antoniadou A, Giamarellou H. Fever of unknown origin in febrile leukopenia. Infect Dis Clin North Am 2007;21:1055–1090.
4. Lima SS, França MS, Godoi CC, Martinho GH, de Jesus LA et al. Neutropenic patients and their infectious complications at a University Hospital. Rev Bras Hematol Hemoter 2013;35:18–22.
5. Hawkey P, Finch R. Tigecycline: in-vitro performance as a predictor of clinical efficacy. Clin Microbiol Infect 2007;13:354–362.
6. Slover CM, Rodvold KA, Danziger LH. Tigecycline: a novel broad-spectrum antimicrobial. Ann Pharmacother 2007;41:965–972.
7. Zhong X, Xu H, Chen D, Zhou H, Hu X et al. First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital. PLoS One 2014;9:e115185.
8. Sun Y, Cai Y, Liu X, Bai N, Liang B et al. The emergence of clinical resistance to tigecycline. Int J Antimicrob Agents 2013;41:110–116.
9. Hornsey M, Ellington MJ, Doumith M, Scott G, Livermore DM et al. Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment. Int J Antimicrob Agents 2010;35:478–481.
10. Chiu SK, Chan MC, Huang LY, Lin YT, Lin JC et al. Tigecycline resistance among carbapenem-resistant Klebsiella pneumoniae: clinical characteristics and expression levels of efflux pump genes. PLoS One 2017;12:e0175140.
11. Ruzin A, Immermann FW, Bradford PA. Real-time PCR and statistical analyses of acrAB and ramA expression in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 2008;52: 3430–3432.
12. Hentschke M, Wolters M, Sobottka I, Rohde H, Aepfelbacher M. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Antimicrob Agents Chemother 2010;54:2720–2723.
13. Deng M, Zhu MH, Li JJ, Bi S, Sheng ZK et al. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital. Antimicrob Agents Chemother 2014;58:297–303.
14. Li R, Han Y, Zhou Y, Du Z, Wu H et al. Tigecycline susceptibility and molecular resistance mechanisms among clinical Klebsiella pneumoniae strains isolated during non-tigecycline treatment. Microb Drug Resist 2017;23:139–146.
15. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000;18:3038–3051.
16. CLSI. M100-S25 Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Fifth Informational Supplement; 2015.
17. Nigo M, Cevallos CS, Woods K, Flores VM, Francis G et al. Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2013;57:5743–5746.
18. van Duin D, Cober ED, Richter SS, Perez F, Cline M et al. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect 2014;20:O1117–O1120.
19. Roy S, Datta S, Viswanathan R, Singh AK, Basu S. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007–10) and role of an efflux pump in tigecycline non-susceptibility. J Antimicrob Chemother 2013;68:1036–1042.
20. Juan CH, Huang YW, Lin YT, Yang TC, Wang FD. Risk factors, outcomes, and mechanisms of tigecycline-nonsusceptible Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother 2016;60: 7357–7363.
21. Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R et al. Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae. J Antimicrob Chemother 2015;70:81–88.
22. Veleba M, Higgins PG, Gonzalez G, Seifert H, Schneiders T. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob Agents Chemother 2012;56:4450–4458.
23. Sheng ZK, Hu F, Wang W, Guo Q, Chen Z et al. Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother 2014;58:6982–6985.
24. Wang X, Chen H, Zhang Y, Wang Q, Zhao C et al. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR. Int J Antimicrob Agents 2015;45: 635–640.
25. Veleba M, Schneiders T. Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae. Antimicrob Agents Chemother 2012;56:4466–4467.
26. Veleba M, de Majumdar S, Hornsey M, Woodford N, Schneiders T. Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Antimicrob Chemother 2013;68:1011–1018.